Home / Guidelines & Products

ICH harmonised guidelines

Through working groups of international regulatory and industry experts, ICH produces harmonised guidelines to support the development and registration of safe, effective and high-quality medicines around the world.

These technical guidelines are developed collaboratively and normally represent a scientific consensus. They are finalised following extensive public and regulatory consultation, approved by ICH’s regulatory members, and then adopted and implemented by regulatory authorities.

ICH work products

New topic proposals


New topics for future harmonisation are proposed and discussed regularly.

MedDRA


A highly specific standardised medical terminology used for registration, reporting and safety monitoring of medical products.

Visit page

ESTRI


Electronic Standards for the Transfer of Regulatory Information for secure transmission, standardised formats and interoperability.

Visit page

CTD


The Common Technical Document, a standardised core dossier format for submitting information to regulators.

Visit page

Digital platform


Technology Task Force, exploring the development of a digital platform to accelerate harmonisation.

Visit page

ICH guidelines

Your search for specific guidelines starts here. Use the search bar and the filters below to navigate the database of documents produced by ICH.

Harmonised
E6(R3) Annex 2

E6(R3) Annex 2 – Good Clinical Practice (GCP): Additional Considerations for Interventional Clinical Trials

Read More
In Process
E6(R3) Annex 2

E6(R3) Annex 2 – Good Clinical Practice (GCP): Additional Considerations for Interventional Clinical Trials

Read More
Pre-harmonisation

E6(R3) Annex 2 – Good Clinical Practice (GCP): Additional Considerations for Interventional Clinical Trials

Read More
Harmonised
E14/S7B

E14/S7B – Questions & Answers: Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential

Read More
In Process
E14/S7B

E14/S7B – Questions & Answers: Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential

Read More
Pre-harmonisation

E14/S7B – Questions & Answers: Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential

Read More
Harmonised
M13B

M13B – Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver

Read More
In Process
M13B

M13B – Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver

Read More
Pre-harmonisation

M13B – Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver

Read More
Harmonised
M11

M11 – Clinical electronic Structured Harmonised Protocol (CeSHarP)

Read More
In Process
M11

M11 – Clinical electronic Structured Harmonised Protocol (CeSHarP)

Read More
Pre-harmonisation

M11 – Clinical electronic Structured Harmonised Protocol (CeSHarP)

Read More
Harmonised
M8

M8 – Electronic Common Technical Document (eCTD)

Read More
In Process
M8

M8 – Electronic Common Technical Document (eCTD)

Read More
Pre-harmonisation

M8 – Electronic Common Technical Document (eCTD)

Read More
Harmonised

Pursuing Opportunities for Harmonisation in Using Real-World Data to Generate Real-World Evidence

Read More
In Process

Pursuing Opportunities for Harmonisation in Using Real-World Data to Generate Real-World Evidence

Read More
Pre-harmonisation

Pursuing Opportunities for Harmonisation in Using Real-World Data to Generate Real-World Evidence

Read More
Harmonised

Patient-Focused Drug Development (PFDD)

Read More
In Process

Patient-Focused Drug Development (PFDD)

Read More
Pre-harmonisation

Patient-Focused Drug Development (PFDD)

Read More
Harmonised

Strategic Approach to Harmonisation of Technical Scientific Requirements for Pharmacoepidemiological Studies

Read More
In Process

Strategic Approach to Harmonisation of Technical Scientific Requirements for Pharmacoepidemiological Studies

Read More
Pre-harmonisation

Strategic Approach to Harmonisation of Technical Scientific Requirements for Pharmacoepidemiological Studies

Read More
View all guidelines

ICH Guideline Implementation

Story title

At Step 5 of the ICH process, harmonised ICH guidelines are implemented by ICH Regulatory Members and Observers within their respective country/region.

Learn more about the implementation status of each ICH harmonised guideline.

Visit the implementation page